Thioisonicotinamide

CAS No. 2196-13-6

Thioisonicotinamide( NSC 1607 | Thioisonicotinamide )

Catalog No. M13498 CAS No. 2196-13-6

Isonicotinamide (pyridine-4-carboxamide) is a chemical based on the nicotinamide structure, but in which the amide is in the 4-position and not the 3-position.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thioisonicotinamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Isonicotinamide (pyridine-4-carboxamide) is a chemical based on the nicotinamide structure, but in which the amide is in the 4-position and not the 3-position.
  • Description
    Isonicotinamide (pyridine-4-carboxamide) is a chemical based on the nicotinamide structure, but in which the amide is in the 4-position and not the 3-position.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 1607 | Thioisonicotinamide
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Tubercle bacillus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2196-13-6
  • Formula Weight
    138.19
  • Molecular Formula
    C6H6N2S
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    NC(=S)C1=CC=NC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamamoto K, et al.Saishin Igaku. 1967 Sep 10;22(9):2087-97.
molnova catalog
related products
  • CORM-401

    CORM-401 is an oxidant-sensitive CO-releasing molecule used in the research of oxidative stress-mediated pathologies and inflammation [inflammatory].

  • Bedaquiline

    Bedaquiline(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism.

  • Daunomycinone

    Daunomycinone (NSC-109351) is a glycan of daunomycin, an antibiotic-class compound representing tumour-inhibiting anthracyclines, used in cancer and leukaemia treatment.